NIH begins long-delayed clinical trials for long Covid, announces new research office
One trial involving Paxlovid is already underway.
WASHINGTON — The National Institutes of Health on Monday took long-delayed steps to begin enrolling patients in clinical trials to test long Covid treatments, and the Department of Health and Human Services created an Office of Long Covid Research that the Biden administration first announced nearly a year ago.
Congress in December 2020 gave the NIH $1.15 billion to research and test treatments for long Covid. The trials were initially supposed to launch last fall but were delayed three separate times, according to documents obtained by STAT and MuckRock.
What's Your Reaction?
